PL3129392T3 - Triterpenoidy o aktywności hamującej dojrzewanie hiv, podstawione w pozycji 3 niearomatycznym pierścieniem zawierającym podstawnik fluorowcoalkilowy - Google Patents

Triterpenoidy o aktywności hamującej dojrzewanie hiv, podstawione w pozycji 3 niearomatycznym pierścieniem zawierającym podstawnik fluorowcoalkilowy

Info

Publication number
PL3129392T3
PL3129392T3 PL15718402T PL15718402T PL3129392T3 PL 3129392 T3 PL3129392 T3 PL 3129392T3 PL 15718402 T PL15718402 T PL 15718402T PL 15718402 T PL15718402 T PL 15718402T PL 3129392 T3 PL3129392 T3 PL 3129392T3
Authority
PL
Poland
Prior art keywords
triterpenoids
substituted
aromatic ring
inhibitory activity
ring carrying
Prior art date
Application number
PL15718402T
Other languages
English (en)
Inventor
Sing-Yuen Sit
Yan Chen
Jie Chen
Jacob Swidorski
Brian Lee Venables
Ny Sin
Nicholas A. Meanwell
Alicia Regueiro-Ren
Richard A. Hartz
Li Xu
Zheng Liu
Original Assignee
VIIV Healthcare UK(No.4) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53002809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3129392(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by VIIV Healthcare UK(No.4) Limited filed Critical VIIV Healthcare UK(No.4) Limited
Publication of PL3129392T3 publication Critical patent/PL3129392T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66Methanesulfonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/121,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/04Esters of boric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL15718402T 2014-04-11 2015-04-09 Triterpenoidy o aktywności hamującej dojrzewanie hiv, podstawione w pozycji 3 niearomatycznym pierścieniem zawierającym podstawnik fluorowcoalkilowy PL3129392T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461978306P 2014-04-11 2014-04-11
PCT/US2015/025029 WO2015157483A1 (en) 2014-04-11 2015-04-09 Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent
EP15718402.9A EP3129392B1 (en) 2014-04-11 2015-04-09 Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent

Publications (1)

Publication Number Publication Date
PL3129392T3 true PL3129392T3 (pl) 2021-04-06

Family

ID=53002809

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15718402T PL3129392T3 (pl) 2014-04-11 2015-04-09 Triterpenoidy o aktywności hamującej dojrzewanie hiv, podstawione w pozycji 3 niearomatycznym pierścieniem zawierającym podstawnik fluorowcoalkilowy

Country Status (36)

Country Link
US (5) US9527882B2 (pl)
EP (2) EP3750910A1 (pl)
JP (1) JP6568202B2 (pl)
KR (1) KR102411082B1 (pl)
CN (1) CN106604909B (pl)
AR (1) AR101077A1 (pl)
AU (1) AU2015243500B2 (pl)
BR (1) BR112016023414B1 (pl)
CA (1) CA2944778C (pl)
CL (1) CL2016002528A1 (pl)
CR (1) CR20160472A (pl)
CY (1) CY1123742T1 (pl)
DK (1) DK3129392T3 (pl)
DO (1) DOP2016000277A (pl)
EA (1) EA030178B1 (pl)
ES (1) ES2828705T3 (pl)
HR (1) HRP20201645T1 (pl)
HU (1) HUE051719T2 (pl)
IL (1) IL248053B (pl)
LT (1) LT3129392T (pl)
MA (1) MA39374A1 (pl)
MX (1) MX374543B (pl)
NZ (1) NZ724644A (pl)
PE (1) PE20161391A1 (pl)
PH (1) PH12016501951B1 (pl)
PL (1) PL3129392T3 (pl)
PT (1) PT3129392T (pl)
RS (1) RS60959B1 (pl)
SG (2) SG11201608041QA (pl)
SI (1) SI3129392T1 (pl)
SM (1) SMT202000581T1 (pl)
TW (1) TWI659964B (pl)
UA (1) UA120927C2 (pl)
UY (1) UY36070A (pl)
WO (1) WO2015157483A1 (pl)
ZA (1) ZA201606748B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3129392T1 (sl) 2014-04-11 2020-11-30 VIIV Healthcare UK(No.4) Limited Triterpenoidi z inhibitorno aktivnostjo maturacije HIV-a, substituirani na položaju 3 z nearomatskim obročem, ki nosi haloalkilni substituent
WO2017085677A2 (en) * 2015-11-20 2017-05-26 ViiV Healthcare UK (No.4) Limited Hiv maturation inhibitor formulations
AR107512A1 (es) * 2016-02-04 2018-05-09 VIIV HEALTHCARE UK Nº 5 LTD Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1
EP3506902A4 (en) * 2016-08-31 2020-04-22 VIIV Healthcare Company COMBINATIONS AND USES AND TREATMENTS THEREOF
ES2970042T3 (es) * 2018-04-24 2024-05-24 Viiv Healthcare Uk No 5 Ltd Compuestos con actividad inhibidora de la maduración del VIH
SMT202300049T1 (it) * 2018-12-10 2023-03-17 Viiv Healthcare Uk No 4 Ltd Sale mesilato di un composto di ammino-lupano con attivita’ di inibizione della maturazione dell’hiv
CN109705189B (zh) * 2018-12-29 2020-06-05 中国医学科学院药用植物研究所 具有式i所示结构的三萜衍生物及其制备方法和应用
CN110981765A (zh) * 2019-11-07 2020-04-10 肇庆巨元生化有限公司 一种25-羟基维生素d3中间体的制备方法
UY38982A (es) * 2019-12-09 2021-06-30 Viiv Healthcare Co Composiciones farmacéuticas

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906661A (en) 1981-11-12 1990-03-06 E. I. Du Pont De Nemours And Company Esters of aryloxypropanolamine derivatives
US5413999A (en) 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
US5679828A (en) 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
AR035311A1 (es) 1999-01-27 2004-05-12 Wyeth Corp Derivados de acido hidroxamico que contienen alquinilo, como inhibidores de las metalloproteinasas de matriz y de la tace, composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento
US20040110785A1 (en) 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US7365221B2 (en) 2002-09-26 2008-04-29 Panacos Pharmaceuticals, Inc. Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
US7745625B2 (en) 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
EP1730163A4 (en) 2004-03-17 2009-12-30 Panacos Pharmaceuticals Inc Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid
TW200628161A (en) 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
WO2008115281A2 (en) 2006-10-16 2008-09-25 Myriad Genetics, Inc. Compounds for treating viral infections
US20090062243A1 (en) * 2007-08-03 2009-03-05 Advanced Life Sciences, Inc. Lupane-Type Triterpenoids Modified at 30-Position and Analogues Thereof
CA2714049A1 (en) 2008-02-14 2009-08-20 Virochem Pharma Inc. Novel 17.beta. lupane derivatives
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
US8802661B2 (en) 2010-06-04 2014-08-12 Bristol-Myers Squibb Company C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors
CN103038245B (zh) * 2010-06-04 2015-03-25 百时美施贵宝公司 作为hiv成熟抑制剂的c-3经修饰的桦木酸衍生物
PL2670764T3 (pl) 2011-01-31 2016-02-29 Bristol Myers Squibb Co C-28 aminy zmodyfikowanych C-3 pochodnych kwasu betulinowego jako inhibitory dojrzewania HIV
KR101886467B1 (ko) 2011-01-31 2018-08-07 비브 헬스케어 유케이 (넘버4) 리미티드 Hiv 성숙 억제 활성을 갖는 c-17 및 c-3 변형 트리테르페노이드
US8906889B2 (en) 2012-02-15 2014-12-09 Bristol-Myers Squibb Company C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
US8889854B2 (en) * 2012-05-07 2014-11-18 Bristol-Myers Squibb Company C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
SI3129392T1 (sl) 2014-04-11 2020-11-30 VIIV Healthcare UK(No.4) Limited Triterpenoidi z inhibitorno aktivnostjo maturacije HIV-a, substituirani na položaju 3 z nearomatskim obročem, ki nosi haloalkilni substituent

Also Published As

Publication number Publication date
BR112016023414B1 (pt) 2022-09-13
MX2016013425A (es) 2017-05-02
BR112016023414A2 (pl) 2017-08-15
LT3129392T (lt) 2020-11-10
PH12016501951B1 (en) 2021-02-19
CN106604909B (zh) 2019-02-15
JP2017510659A (ja) 2017-04-13
KR102411082B1 (ko) 2022-06-17
ZA201606748B (en) 2018-05-30
KR20160147809A (ko) 2016-12-23
AR101077A1 (es) 2016-11-23
PE20161391A1 (es) 2017-01-10
EP3129392A1 (en) 2017-02-15
DOP2016000277A (es) 2017-02-28
IL248053B (en) 2020-04-30
CA2944778C (en) 2022-06-14
MA39374A1 (fr) 2018-06-29
CL2016002528A1 (es) 2017-06-23
UA120927C2 (uk) 2020-03-10
TW201623324A (zh) 2016-07-01
EP3750910A1 (en) 2020-12-16
DK3129392T3 (da) 2020-10-19
AU2015243500A1 (en) 2016-10-27
US10780102B2 (en) 2020-09-22
SMT202000581T1 (it) 2020-11-10
US20170340650A1 (en) 2017-11-30
CN106604909A (zh) 2017-04-26
SG10201709017PA (en) 2017-11-29
AU2015243500B2 (en) 2017-03-30
RS60959B1 (sr) 2020-11-30
MX374543B (es) 2025-03-06
PT3129392T (pt) 2020-10-30
WO2015157483A1 (en) 2015-10-15
US20190151336A1 (en) 2019-05-23
NZ724644A (en) 2023-07-28
IL248053A0 (en) 2016-11-30
EP3129392B1 (en) 2020-08-05
ES2828705T3 (es) 2021-05-27
US10245275B2 (en) 2019-04-02
US9527882B2 (en) 2016-12-27
CA2944778A1 (en) 2015-10-15
US20170056420A1 (en) 2017-03-02
EA201691760A1 (ru) 2017-02-28
HUE051719T2 (hu) 2021-03-29
UY36070A (es) 2015-10-30
JP6568202B2 (ja) 2019-08-28
SI3129392T1 (sl) 2020-11-30
SG11201608041QA (en) 2016-10-28
US11464790B2 (en) 2022-10-11
US20200360404A1 (en) 2020-11-19
TWI659964B (zh) 2019-05-21
PH12016501951A1 (en) 2017-01-09
CR20160472A (es) 2017-03-10
HRP20201645T1 (hr) 2020-12-25
EA030178B1 (ru) 2018-06-29
CY1123742T1 (el) 2022-03-24
US20150291655A1 (en) 2015-10-15

Similar Documents

Publication Publication Date Title
NL301329I2 (nl) Lazertinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
ZA201606748B (en) Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent
NL301260I2 (nl) Gefapixant, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.
ZA201704556B (en) Picolinamides with fungicidal activity
GB202015694D0 (en) Hardware to implement a convolutional neural network
SG11201508240XA (en) Suitcase, especially a pilot suitcase
AU359973S (en) A flask
IL240289A0 (en) c19-modified triterpenoids with HIV maturation inhibitory activity
PL3230481T3 (pl) Stop ferrytyczny
IT201600122159A1 (it) Cursore per una cerniera lampo.
ZA201900684B (en) A structural member
EP3194030A4 (en) Substituted phenylpyrrolecarboxamides with therapeutic activity in hiv
FR3025844B1 (fr) Servovalve a tiroir composite
HK1232548A1 (en) Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent
GB2548428B (en) Nondeterministic response to a challenge
IL252132A0 (en) Pasta with a new shape
FR3030149B1 (fr) Actionneur a encombrement reduit, avec conducteurs en s
SI3119380T1 (sl) Sestavek, ki obsega čebelje izdelke
Mallick et al. Graphics Miscellanea
GB201405571D0 (en) P.o.o.n.t.a.n.g.i.n.g
TH1601000974B (th) เครื่องพ่นมีต้นกำลังสะพายหลัง
GB201313848D0 (en) R.i.l.a.s
ITTN20140008U1 (it) Alzalenzuolo, intercapedine formata da un arco per il letto
AU2014903733A0 (en) A stud
AU2014900695A0 (en) A garment